Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to $5.4 million.

  • Aspen Aerogels' Depreciation & Amortization (CF) rose 188.68% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.4 million, marking a year-over-year increase of 373.76%. This contributed to the annual value of $22.5 million for FY2024, which is 4705.58% up from last year.
  • Aspen Aerogels' Depreciation & Amortization (CF) amounted to $5.4 million in Q3 2025, which was up 188.68% from $5.8 million recorded in Q2 2025.
  • Aspen Aerogels' 5-year Depreciation & Amortization (CF) high stood at $6.0 million for Q2 2024, and its period low was $2.1 million during Q2 2022.
  • In the last 5 years, Aspen Aerogels' Depreciation & Amortization (CF) had a median value of $3.5 million in 2023 and averaged $3.9 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first tumbled by 1933.28% in 2022, then skyrocketed by 11449.7% in 2024.
  • Quarter analysis of 5 years shows Aspen Aerogels' Depreciation & Amortization (CF) stood at $2.5 million in 2021, then decreased by 0.71% to $2.5 million in 2022, then soared by 79.14% to $4.5 million in 2023, then increased by 20.1% to $5.4 million in 2024, then decreased by 0.48% to $5.4 million in 2025.
  • Its Depreciation & Amortization (CF) was $5.4 million in Q3 2025, compared to $5.8 million in Q2 2025 and $5.8 million in Q1 2025.